In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease von Lund, Thomas, Gundesen, Michael Tveden, Juul Vangsted, Annette, Helleberg, Carsten, Haukås, Einar, Silkjær, Trine, Asmussen, Jon Thor, Manuela Teodorescu, Elena, Amdi Jensen, Bo, Schmidt Slørdahl, Tobias, Nahi, Hareth, Waage, Anders, Abildgaard, Niels, Schjesvold, Fredrik

Volltext

Plasma Cell Leukemia: Definition, Presentation, and Treatment von Gundesen, Michael Tveden, Lund, Thomas, Moeller, Hanne E. H., Abildgaard, Niels

Volltext

P-132 Daratumumab Treatment in the Patients’ Own Home von Lund, Thomas, Kirkegaard, Jannie, Gundesen, Michael Tveden, Dieperink, Karin Brochstedt, Rosenberg, Tine

Volltext

Home is best. Self-administration of subcutaneous Bortezomib at home in patients with multiple myeloma - A mixed method study von Kirkegaard, Jannie, Lundholm, Birgitte Wolf, Rosenberg, Tine, Lund, Thomas, Gundesen, Michael Tveden, Dieperink, Karin Brochstedt

Volltext

Stable MGUS and SMM Are Characterized By Distinct Senescent Features in the Pre-Malignant Plasma Cells and the Proximate Bone Microenvironment von Alvares Borges, Gabriel, Diaz-Delcastillo, Marta, Guilatco, Angelo Jose, Mustapha, Fatima Ali, El Masari, Bilal, Gundesen, Michael Tveden, Hinge, Maja, Nyvold, Charlotte Guldborg, Lund, Thomas, Tchkonia, Tamar, Kirkland, James L., Kourelis, Taxiarchis, Drake, Matthew T., Andersen, Thomas Levin, Weivoda, Megan

Volltext

Novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myeloma von Anloague, Aric, Sabol, Hayley M, Kaur, Japneet, Khan, Sharmin, Ashby, Cody, Schinke, Carolina, Barnes, C Lowry, Alturkmani, Farah, Ambrogini, Elena, Gundesen, Michael Tveden, Lund, Thomas, Amstrup, Anne Kristine, Andersen, Thomas Levin, Diaz-delCastillo, Marta, Roodman, G David, Bellido, Teresita, Delgado-Calle, Jesus

Volltext

Increased Bone Volume by Ixazomib in Multiple Myeloma: 3‐Month Results from an Open Label Phase 2 Study von Diaz‐delCastillo, Marta, Gundesen, Michael Tveden, Andersen, Christian Walther, Nielsen, Anne Lerberg, Møller, Hanne Elisabeth Højsgaard, Vinholt, Pernille Just, Asmussen, Jon Thor, Kristensen, Ida Bruun, Nyvold, Charlotte Guldborg, Abildgaard, Niels, Levin Andersen, Thomas, Lund, Thomas

Volltext

Making decisions for follow-up chemotherapy based on digital patient reported outcomes data in patients with multiple myeloma and other M protein diseases – A mixed method study von Rosenberg, Tine, Kirkegaard, Jannie, Tveden, Michael Gundesen, Hyldig, Nana, Dieperink, Karin Brochstedt, Steffensen, Nanna Hanneberg, Ulriksen, Stine Brøgger, Lund, Thomas

Volltext

Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma von El-Masri, Bilal M, Leka, Benedeta, Mustapha, Fatima, Gundesen, Michael Tveden, Hinge, Maja, Lund, Thomas, Andersen, Thomas L, Diaz-delCastillo, Marta, Jafari, Abbas

Volltext

High levels of c-Met is associated with poor prognosis in glioblastoma von Petterson, Stine Asferg, Dahlrot, Rikke Hedegaard, Hermansen, Simon Kjær, K. A. Munthe, Sune, Gundesen, Michael Tveden, Wohlleben, Helle, Rasmussen, Tine, Beier, Christoph Patrick, Hansen, Steinbjørn, Kristensen, Bjarne Winther

Volltext

P-349 Multiple Myeloma Patients Who Are in VGPR or Better Benefits From Continued Treatment With Zoledronic Acid Beyond Two Years von Lund, Thomas, Gundesen, Michael Tveden, Vangsted, Annette Juul, Helleberg, Carsten, Haukås, Einar, Silkjær, Trine, Asmussen, Jon Thor, Teodorescu, Elena Manuela, Jensen, Bo Amdi, Slørdahl, Tobias, Nahi, Hareth, Waage, Anders, Abildgaard, Niels, Schjesvold, Fredrik

Volltext

Novel Developments in the Treatment of Multiple Myeloma-Associated Bone Disease von Johansen, Martin, Levring, Mette Bøegh, Stokbro, Kasper, Diaz-delCastillo, Marta, Khan, Abdul Ahad, Wickstroem, Line Adsbøll, Gundesen, Michael Tveden, Kristensen, Ida Bruun, Nyvold, Charlotte Guldborg, Andersen, Mikkel Østerheden, Andersen, Thomas Levin, Abildgaard, Niels, Lund, Thomas

Volltext